A novel approach to creating inhalable vaccines using nanoparticles has been uncovered by researchers, showing promise for targeting lung-specific diseases, such as influenza, pneumonia and tuberculosis.
A novel approach to creating inhalable vaccines using nanoparticles has been uncovered by researchers, showing promise for targeting lung-specific diseases, such as influenza, pneumonia and tuberculosis.